Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by López-Cabrera, M.
Right arrow Articles by Sánchez-Madrid, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by López-Cabrera, M.
Right arrow Articles by Sánchez-Madrid, F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 270, Number 37, Issue of September 15, pp. 21545-21551, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Transcriptional Regulation of the Gene Encoding the Human C-type Lectin Leukocyte Receptor AIM/CD69 and Functional Characterization of Its Tumor Necrosis Factor--responsive Elements

(Received for publication, June 12, 1995)

Manuel López-Cabrera ,&nbsp;<WBR> Eduardo Muñoz ,&nbsp;<WBR> M. Valle Blázquez ,&nbsp;<WBR> Maria A. Ursa Ana G. Santis Francisco Sánchez-Madrid

The human activation antigen CD69 is a member of the C-type animal lectin superfamily that functions as a signal-transmitting receptor. Although the expression of CD69 can be induced in vitro on cells of most hematopoietic lineages with a wide variety of stimuli, in vivo it is mainly expressed by T-lymphocytes located in the inflammatory infiltrates of several human diseases. To elucidate the mechanisms that regulate the constitutive and inducible expression of CD69 by leukocytes, we isolated the promoter region of the CD69 gene and carried out its functional characterization. Sequence analysis of the 5`-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors (NF-kappaB, Egr-1, AP-1), which might mediate the inducible expression of this gene. Transient expression of CD69 promoter-based reporter gene constructs in K562 cells indicated that the proximal promoter region spanning positions -78 to +16 contained the cis-acting sequences necessary for basal and phorbol 12-myristate 13-acetate-inducible transcription of the CD69 gene. Removal of the upstream sequences located between positions -78 and -38 resulted in decreased promoter strength and abolished the response to phorbol 12-myristate 13-acetate. We also found that tumor necrosis factor-alpha (TNF-alpha) is capable of inducing the surface expression of the CD69 molecule as well as the promoter activity of fusion plasmids that contain 5`-flanking sequences of the CD69 gene, suggesting that this cytokine may regulate in vivo the expression of CD69. In addition, cotransfection experiments demonstrated that the CD69 gene promoter can be activated by the NF-kappaB/Rel family members c-Rel and RelA. The deletion of the sequence spanning positions -255 to -170 abolished both the response to TNF-alpha and the transactivation by NF-kappaB. These results indicate that the NF-kappaB-binding site located at position -223 is necessary for the TNF-alpha-induced expression of the CD69 gene. Mobility shift assays showed that the two NF-kappaB motifs located in the proximal promoter region (positions -223 and -160) bind various NF-kappaB-related complexes, including the heterodimers p50/RelA and p50/c-Rel and homodimers of p50 (KBF-1) and RelA. Our findings help to explain the regulated synthesis of CD69 in vivo and suggest that TNF-alpha has a key role in the expression of this molecule at sites of chronic inflammation.




Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Zhang, N. Zhang, and D. L. Mueller
Casitas B-Lineage Lymphoma b Inhibits Antigen Recognition and Slows Cell Cycle Progression at Late Times during CD4+ T Cell Clonal Expansion
J. Immunol., October 15, 2008; 181(8): 5331 - 5339.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Alonso, M. C. Rodriguez, J. Pindado, E. Merino, I. Merida, and M. Izquierdo
Diacylglycerol Kinase {alpha} Regulates the Secretion of Lethal Exosomes Bearing Fas Ligand during Activation-induced Cell Death of T Lymphocytes
J. Biol. Chem., August 5, 2005; 280(31): 28439 - 28450.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Pignatelli, J. Sanchez-Rodriguez, A. Santos, and A. Perez-Castillo
15-Deoxy-{Delta}-12,14-prostaglandin J2 induces programmed cell death of breast cancer cells by a pleiotropic mechanism
Carcinogenesis, January 1, 2005; 26(1): 81 - 92.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. M. Siwkowski, L. A. Madge, S. Koo, E. L. McMillan, B. P. Monia, J. S. Pober, and B. F. Baker
Effects of Antisense Oligonucleotide-Mediated Depletion of Tumor Necrosis Factor (TNF) Receptor 1-Associated Death Domain Protein on TNF-Induced Gene Expression
Mol. Pharmacol., September 1, 2004; 66(3): 572 - 579.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Lara-Pezzi, N. Pezzi, I. Prieto, I. Barthelemy, C. Carreiro, A. Martinez, A. Maldonado-Rodriguez, M. Lopez-Cabrera, and J. L. Barbero
Evidence of a Transcriptional Co-activator Function of Cohesin STAG/SA/Scc3
J. Biol. Chem., February 20, 2004; 279(8): 6553 - 6559.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
E. Esplugues, D. Sancho, J. Vega-Ramos, C. Martinez-A, U. Syrbe, A. Hamann, P. Engel, F. Sanchez-Madrid, and P. Lauzurica
Enhanced Antitumor Immunity in Mice Deficient in CD69
J. Exp. Med., May 5, 2003; 197(9): 1093 - 1106.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C.-C. Ku, J. A. Padilla, C. Grose, E. C. Butcher, and A. M. Arvin
Tropism of Varicella-Zoster Virus for Human Tonsillar CD4+ T Lymphocytes That Express Activation, Memory, and Skin Homing Markers
J. Virol., October 11, 2002; 76(22): 11425 - 11433.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. D. Richards, S. H. Dave, C.-H. G. Chou, A. A. Mamchak, and A. L. DeFranco
Inhibition of the MEK/ERK Signaling Pathway Blocks a Subset of B Cell Responses to Antigen
J. Immunol., March 15, 2001; 166(6): 3855 - 3864.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Yu, T. Matsui, M. Otsuka, T. Sekine, K. Yamamoto, K. Nishioka, and T. Kato
Anti-CD69 Autoantibodies Cross-React with Low Density Lipoprotein Receptor-Related Protein 2 in Systemic Autoimmune Diseases
J. Immunol., January 15, 2001; 166(2): 1360 - 1369.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Lauzurica, D. Sancho, M. Torres, B. Albella, M. Marazuela, T. Merino, J. A. Bueren, C. Martinez-A, and F. Sanchez-Madrid
Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice
Blood, April 1, 2000; 95(7): 2312 - 2320.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. L. Prehn, C. J. Landers, and S. R. Targan
A Soluble Factor Produced by Lamina Propria Mononuclear Cells Is Required for TNF-{alpha} Enhancement of IFN-{gamma} Production by T Cells
J. Immunol., October 15, 1999; 163(8): 4277 - 4283.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. H. Idris, K. Iizuka, H. R.C. Smith, A. A. Scalzo, and W. M. Yokoyama
Genetic Control Of Natural Killing and In Vivo Tumor Elimination by the Chok Locus
J. Exp. Med., December 21, 1998; 188(12): 2243 - 2256.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. F. Romano, A. Lamberti, P. Tassone, F. Alfinito, S. Costantini, F. Chiurazzi, T. Defrance, P. Bonelli, F. Tuccillo, M. C. Turco, et al.
Triggering of CD40 Antigen Inhibits Fludarabine-Induced Apoptosis in B Chronic Lymphocytic Leukemia Cells
Blood, August 1, 1998; 92(3): 990 - 995.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
H. Shao, D. H. Kono, L.-Y. Chen, E. M. Rubin, and J. Kaye
Induction of the Early Growth Response (Egr) Family of Transcription Factors during Thymic Selection
J. Exp. Med., February 17, 1997; 185(4): 731 - 744.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Santana, G. Pedraza-Alva, N. Olivares-Zavaleta, V. Madrid-Marina, V. Horejsi, S. J. Burakoff, and Y. Rosenstein
CD43-mediated Signals Induce DNA Binding Activity of AP-1, NF-AT, and NFkappa B Transcription Factors in Human T Lymphocytes
J. Biol. Chem., September 29, 2000; 275(40): 31460 - 31468.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement